Integrated Diagnostics Holdings (CHIX:IDHCL) Additional Paid-In Capital : $20.99 Mil(As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Integrated Diagnostics Holdings Additional Paid-In Capital?

Integrated Diagnostics Holdings's quarterly additional paid-in capital declined from Mar. 2024 ($22.78 Mil) to Jun. 2024 ($21.54 Mil) but then stayed the same from Jun. 2024 ($21.54 Mil) to Dec. 2024 ($20.99 Mil).

Integrated Diagnostics Holdings's annual additional paid-in capital declined from Dec. 2022 ($41.72 Mil) to Dec. 2023 ($33.25 Mil) and declined from Dec. 2023 ($33.25 Mil) to Dec. 2024 ($20.99 Mil).

Integrated Diagnostics Holdings Additional Paid-In Capital Historical Data

The historical data trend for Integrated Diagnostics Holdings's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integrated Diagnostics Holdings Additional Paid-In Capital Chart

Integrated Diagnostics Holdings Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Additional Paid-In Capital

Get a 7-Day Free Trial

65.48

65.42

41.72

33.25

20.99

Integrated Diagnostics Holdings Quarterly Data
	Dec18	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23	Mar24	Jun24	Dec24
Additional Paid-In Capital	Get a 7-Day Free Trial															33.27	33.25	22.78	21.54	20.99

Integrated Diagnostics Holdings Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Integrated Diagnostics Holdings Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Integrated Diagnostics Holdings's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Integrated Diagnostics Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Integrated Diagnostics Holdings PLC (CHIX:IDHCl) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

IDGXF:USA IDHC:UK 8I8:Germany

Address

IFC 5, Saint Helier, JEY, JE1 1ST

Website

https://www.idhcorp.com

Integrated Diagnostics Holdings PLC is active in the healthcare sector. It is a fully integrated diagnostics service provider, operating through brands such as Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan and Ultralab and Al Mokhtabar Sudan in Sudan, Echo-Lab in Nigeria; and Biolab KSA in Saudi Arabia. The company specializes in diagnostic tests, ranging from basic tests, such as glucose testing for diabetes, to molecular tests for hepatitis and specialized DNA tests. The company operates in two segments, Contract Segment which generates key revenue, and the Walk-in Segment. It derives a majority of its revenue from services offered in Egypt.

Integrated Diagnostics Holdings Headlines

No Headlines